Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study is a multi-center, randomized, double-blind Phase III Clinical trial. The purpose of this study is to assess the immunogenicity and safety of the quadrivalent cell culture-derived influenza vaccine compare to the trivalent cell culture-derived influenza vaccine in children aged 6\~35 months.
Epistemonikos ID: 6f68870e961d55806a958a4b1ae1aa3cebaf87a9
First added on: May 20, 2024